Hofseth BioCare ASA (OSL: HBC)
Norway
· Delayed Price · Currency is NOK
1.300
-0.040 (-2.99%)
Nov 21, 2024, 4:25 PM CET
Hofseth BioCare ASA Revenue
Hofseth BioCare ASA had revenue of 67.89M NOK in the quarter ending September 30, 2024, with 36.08% growth. This brings the company's revenue in the last twelve months to 248.08M, up 21.19% year-over-year. In the year 2023, Hofseth BioCare ASA had annual revenue of 218.51M with 81.42% growth.
Revenue (ttm)
248.08M
Revenue Growth
+21.19%
P/S Ratio
2.20
Revenue / Employee
3.54M
Employees
71
Market Cap
550.85M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 218.51M | 98.06M | 81.42% |
Dec 31, 2022 | 120.45M | 32.83M | 37.47% |
Dec 31, 2021 | 87.62M | 18.36M | 26.52% |
Dec 31, 2020 | 69.25M | 1.47M | 2.17% |
Dec 31, 2019 | 67.78M | 7.04M | 11.59% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nordhealth AS | 513.12M |
Medistim ASA | 541.82M |
Carasent ASA | 264.80M |
Photocure ASA | 526.25M |
Nykode Therapeutics AS | 69.44M |
ArcticZymes Technologies ASA | 110.76M |
Gentian Diagnostics ASA | 154.12M |
Navamedic ASA | 525.55M |
Hofseth BioCare ASA News
- 13 days ago - Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT - GlobeNewsWire
- 3 months ago - Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT - GlobeNewsWire
- 5 months ago - Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY - GlobeNewsWire
- 6 months ago - Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT - GlobeNewsWire
- 1 year ago - Hofseth Biocare ASA: THIRD QUARTER 2023 FINANCIAL REPORT - GlobeNewsWire
- 1 year ago - Hofseth Biocare ASA: FOURTH QUARTER 2022 & FULL YEAR FINANCIAL REPORT - GlobeNewsWire
- 2 years ago - Hofseth Biocare ASA: HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE - GlobeNewsWire
- 3 years ago - Hofseth Biocare ASA: GLOBAL INNOVATION PARTNERSHIP WITH CATALENT TO DEVELOP DELAYED-RELEASE FORMULATION OF OMEGO FISH OIL - GlobeNewsWire